Skip to Content

Whistleblower Qui Tam Representative Settlements

State of California v. Schering-Plough Corporation

Status:Settled
Settlement Amount: $21.3 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
On December 17, 2009, Schering-Plough Corporation (now known as Merck & Co.) agreed to pay $21.3 million to settle qui tam allegations that it knowingly inflated the prices of its drugs, causing California's Medicaid Program, Medi-Cal, to overpay...

State of Florida v. Dey

Status:Settled
Settlement Amount: $6.5 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
The State of Florida recently settled a whistleblower case against three pharmaceutical manufacturers and their corporate affiliates. The case, which was originally filed by a whistleblower represented by the Whistleblower / Qui Tam Group, involved...

United States ex rel. Ven-A-Care of the Florida Keys, Inc. v. Apothecon, Inc.

Status:Settled
Settlement Amount: $515 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
Berger & Montague represented the whistleblower, Ven-A-Care of the Florida Keys, Inc., a small pharmacy from Key West, Florida. The case included allegations that Apothecon submitted false and inflated Average Wholesale Prices (AWPs) for a number of...

United States ex rel. Ven-A-Care of the Florida Keys, Inc. v. Bristol Myers Squibb Co.

Status:Settled
Settlement Amount: $515 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
Berger & Montague represented the whistleblower, Ven-A-Care of the Florida Keys, Inc., a small pharmacy from Key West, Florida. The case included allegations that Bristol submitted false and inflated Average Wholesale Prices (AWPs) for a number of...

United States v. AstraZeneca Pharmaceuticals, LP

Status:Settled
Settlement Amount: $124 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
In October 2009, the United States, through the U.S. Attorney's Office in New Hampshire, recovered $124 million from four drug companies -- Mylan Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, UDL Laboratories Inc. and Ortho McNeil Pharmaceutical...

United States v. Aventis Pharmaceuticals Inc.

Status:Settled
Settlement Amount: $190 million
Practice Area(s): Whistleblowers, Qui Tam & False Claims Act
In September 2007, Aventis Pharmaceuticals Inc. (now known as Sanofi-Aventis SA) paid $190 million to the United States, a number of states and the District of Columbia to settle a qui tam lawsuit alleging that the company caused false claims to be...